Health
Johnson & Johnson’s Experimental COVID-19 Vaccine Protects Monkeys in a Single Dose, US Firm Kicks-Off – LatestLY
Amid the reports of 4.5 million people affected from COVID-19 in the United States, Johnson & Johnson on Thursday initiated US human safety trials for its COVID-19 vaccine. The coronavirus vaccine trials were kicked off after study in monkeys showed J&…
Chicago, July 30: Amid the reports of 4.5 million people affected from COVID-19 in the United States, Johnson & Johnson on Thursday initiated US human safety trials for its COVID-19 vaccine. The coronavirus vaccine trials were kicked off after study in monkeys showed J&J’s best-performing vaccine candidate offered strong protection in a single dose.
According to a report, published in Reuters, six out of six monkeys were found completely protected from lung disease. Also, five out of th…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Business20 hours agoOwn the world with these 3 global ASX ETFs
-
Noosa News24 hours agoQueensland police to be given powers to issue on-the-spot orders to domestic violence perpetrators
-
Business20 hours agoASX 200 plunges as US tariffs fall-out continues